Login / Signup
Guangbin Peng
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Double Blind
Phase Iii
Placebo Controlled
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
David S Hong
,
Michael A Postow
,
Bartosz Chmielowski
,
Ryan J Sullivan
,
Amita Patnaik
,
Ezra E W Cohen
,
Geoffrey I Shapiro
,
Conor E Steuer
,
Martin Gutierrez
,
Heather Yeckes-Rodin
,
Robert Ilaria
,
Brenda C O'Connell
,
Joanna Peng
,
Guangbin Peng
,
Nora Zizlsperger
,
Anthony W Tolcher
,
Jedd D Wolchok
Eganelisib, a First-in-Class PI3K-γ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)